SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO)
TWD 92.3
(-9.95%)
TWD 92.3
(-9.95%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 251.01 Million TWD | -14.99% |
| 2022 | 295.28 Million TWD | 66.68% |
| 2021 | 177.16 Million TWD | -5.13% |
| 2020 | 186.74 Million TWD | 17.1% |
| 2019 | 159.47 Million TWD | 3.56% |
| 2018 | 153.99 Million TWD | 157.6% |
| 2017 | 59.77 Million TWD | -62.28% |
| 2016 | 158.46 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 87.38 Million TWD | 243.05% |
| 2024 Q2 | 98.6 Million TWD | 12.84% |
| 2023 FY | 251.01 Million TWD | -14.99% |
| 2023 Q1 | 65.52 Million TWD | 181.21% |
| 2023 Q2 | 67.54 Million TWD | 3.08% |
| 2023 Q4 | 25.47 Million TWD | -72.45% |
| 2023 Q3 | 92.47 Million TWD | 36.92% |
| 2022 Q1 | 34.24 Million TWD | 2325.07% |
| 2022 Q4 | 23.3 Million TWD | -79.44% |
| 2022 Q3 | 113.33 Million TWD | 64.68% |
| 2022 Q2 | 68.82 Million TWD | 100.99% |
| 2022 FY | 295.28 Million TWD | 66.68% |
| 2021 Q3 | 28.2 Million TWD | 0.0% |
| 2021 FY | 177.16 Million TWD | -5.13% |
| 2021 Q4 | 1.41 Million TWD | -94.99% |
| 2020 FY | 186.74 Million TWD | 17.1% |
| 2019 FY | 159.47 Million TWD | 3.56% |
| 2018 FY | 153.99 Million TWD | 157.6% |
| 2017 FY | 59.77 Million TWD | -62.28% |
| 2016 FY | 158.46 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 584.75% |
| Level Biotechnology Inc. | 62.9 Million TWD | -299.035% |
| Sagittarius Life Science Corp | -55.03 Million TWD | 556.064% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 488.295% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 228.85% |
| GlycoNex Incorporation | -178.36 Million TWD | 240.732% |
| VBI | -6.6 Million TWD | 3902.651% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 250.967% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | 2449.869% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | 757.584% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 249.354% |
| Visgeneer Inc. | -19.58 Million TWD | 1381.398% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 136.76% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 59.883% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | -246.703% |
| Neith Corporation | -40.03 Million TWD | 727.015% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 121.642% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | 4251.034% |
| Enimmune corporation | -223.74 Million TWD | 212.188% |
| TaiRx, Inc. | -212.29 Million TWD | 218.24% |
| CHO Pharma, Inc. | -306.08 Million TWD | 182.007% |
| EirGenix Inc. | -915.2 Million TWD | 127.427% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | -404.62% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | 496.42% |
| Lin BioScience, Inc. | -687.19 Million TWD | 136.527% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 260.571% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | -1001.321% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 442.516% |
| Lukas Biomedical Inc. | -47.35 Million TWD | 630.089% |
| RBC Bioscience Corporation | 6.43 Million TWD | -3803.779% |
| BiOptic Inc. | 37.74 Million TWD | -564.988% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 136.483% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | 775.402% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 507.886% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 8.665% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 372.514% |
| NaviFUS Corp. | -65.72 Million TWD | 481.891% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 384.954% |
| Sinew Pharma Inc. | -170.92 Million TWD | 246.859% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 468.276% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | -92.106% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 205.449% |
| AP Biosciences Inc | -339.29 Million TWD | 173.981% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 144.72% |
| 3D Global Biotech Inc. | -57.95 Million TWD | 533.147% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | -2868.46% |
| Intech Biopharm Corporation | -337.98 Million TWD | 174.267% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 119.119% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 586.337% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 247.064% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 53.464% |
| TCI GENE Inc. | 11.67 Million TWD | -2050.373% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 296.799% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 184.714% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 215.402% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | -2380.366% |
| PharmaEngine, Inc. | 274.65 Million TWD | 8.606% |
| Savior Lifetec Corporation | 30.03 Million TWD | -735.874% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | -83.582% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 123.987% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 300.256% |
| Acepodia, Inc. | -817.31 Million TWD | 130.712% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 151.389% |